Hypertension among people with diabetes mellitus: Prospective study

Hashim Mustfa Al nuemi; Radhwan Hussein Ibrahim

doi:10.53730/ijhs.v6nS5.10783

Authors

Hashim Mustfa Al nuemi College of Nursing, University of Mosul, Mosul City, Iraq
Radhwan Hussein Ibrahim College of Nursing, University of Mosul, Mosul City, Iraq

Keywords:

Hypertension, Diabetes Mellitus, Mosul

Abstract

Background & Aim: Hypertension is a leading cause of death and disability in people with type 2 diabetes mellitus (T2DM). Despite the fact that type 2 diabetes is more common in City of Mosul-Iraq, little is known about the prevalence of hypertension and the risk factors that go along with it in people with the disease. It was therefore necessary to investigate the prevalence and related variables of hypertension in type 2 diabetes mellitus patients. Methods & Materials: For this study, a tertiary care diabetes clinics from November 2021 to April 2022 were surveyed. Patients with type 2 diabetes at the Al Wafa clinics of were included in the study's source population. A systematic interviewer-administered questionnaire was used to collect data. SPSS software was used to capture the data. Results: (66.7) percent of the (600) participants were women, with a mean age of 53.84 years and a range of 18 to 68 years, more than a quarter of individuals were current smokers, frequent exercisers with obesity, and more than a third were obese and centrally obese.

Downloads

Download data is not yet available.

References

Abdissa, D., & Kene, K. (2020). Prevalence and determinants of hypertension among diabetic patients in jimma university medical center, southwest Ethiopia, 2019. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 2317.

Abdulah, A. A. F. A. (2014). The Risk Factors among Hypertensive Patients at Al kalakla Health Centers, Khartoum State, Sudan (2013). University of Gezira,

Ahmed, S. M., Sami, W., Alanazi, H., Aljarbaa, T., Alkhamis, S., & Almutiri, F. (2015). A study of risk factors for Diabetes & hypertension among Expatriate workers in Majmaah city, Saudi Arabia. Int. J. Health Rehabil. Sci.(IJHRS), 4, 103-114.

Aniza, I., Nurmawati, A., Hanizah, Y., & Ahmad Taufik, J. (2016). Modifiable risk factors of cardiovascular disease among adults in rural community of Malaysia: a cross sectional study. Malaysian Journal of Public Health Medicine, 16(1), 53-61.

Arjunan, C. (2020). A Study on Serum Uric Acid Levels in Type 2 Diabetes Patients and Its Association with Cardiovascular Disease. Tirunelveli Medical College, Tirunelveli,

Avilova, K. X., & Muslimakhon, A. (2022). RISK FACTORS FOR CARDIOVASCULAR DISEASES. Барқарорлик ва Етакчи Тадқиқотлар онлайн илмий журнали, 2(1), 268-273.

Awoke, A., Awoke, T., Alemu, S., & Megabiaw, B. (2012). Prevalence and associated factors of hypertension among adults in Gondar, Northwest Ethiopia: a community based cross-sectional study. BMC cardiovascular disorders, 12(1), 1-6.

Bouchard, C., Blair, S. N., & Haskell, W. L. (2012). Physical activity and health: Human Kinetics.

Carlsson, S., Andersson, T., Talbäck, M., & Feychting, M. (2021). Mortality rates and cardiovascular disease burden in type 2 diabetes by occupation, results from all Swedish employees in 2002–2015. Cardiovascular Diabetology, 20(1), 1-10.

Carvalho, D. S., de Almeida, A. A., Borges, A. F., & Campos, D. V. (2018). Treatments for diabetes mellitus type II: new perspectives regarding the possible role of calcium and cAMP interaction. European journal of pharmacology, 830, 9-16.

Chan, Q., Wren, G. M., Lau, C.-H. E., Ebbels, T., Gibson, R., Loo, R. L., . . . Steffen, L. M. (2022). Blood pressure interactions with the DASH dietary pattern, sodium, and potassium: The International Study of Macro-/Micronutrients and Blood Pressure (INTERMAP). The American journal of clinical nutrition.

Charlton, R., Green, A., Shaddick, G., Snowball, J., Nightingale, A., Tillett, W., . . . Parkinson Andrew Spackman Eldon, P. s. g. B. A. B. L. B. M. B. S. C. L. D. C. D. E. F. C. F. O. H. H. H. P. J. J. M. V. P. J. (2019). Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study. Rheumatology, 58(1), 144-148.

Ciumărnean, L., Milaciu, M. V., Negrean, V., Orășan, O. H., Vesa, S. C., Sălăgean, O., . . . Vlaicu, S. I. (2021). Cardiovascular risk factors and physical activity for the prevention of cardiovascular diseases in the elderly. International journal of environmental research and public health, 19(1), 207.

Cryer, M. J., Horani, T., & DiPette, D. J. (2016). Diabetes and hypertension: a comparative review of current guidelines. The journal of clinical hypertension, 18(2), 95-100.

Dalo, A., Yarlagadda, R., & Tatiparthi, R. (2017). Assessment of asthma treatment outcomes among adult outpatients at Nemmh Chest Clinic in Hadiya Zone, Southern Ethiopia. Journal of basic and clinical pharmacy, 8(3).

Di Giosia, P., Giorgini, P., Stamerra, C. A., Petrarca, M., Ferri, C., & Sahebkar, A. (2018). Gender differences in epidemiology, pathophysiology, and treatment of hypertension. Current atherosclerosis reports, 20(3), 1-7.

do Vale Moreira, N. C., Hussain, A., Bhowmik, B., Mdala, I., Siddiquee, T., Fernandes, V. O., . . . Meyer, H. E. (2020). Prevalence of metabolic syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5), 1217-1224.

Eliasson, B. (2003). Cigarette smoking and diabetes. Progress in cardiovascular diseases, 45(5), 405-413.

Fan, W. (2017). Epidemiology in diabetes mellitus and cardiovascular disease. Cardiovascular endocrinology, 6(1), 8.

Glovaci, D., Fan, W., & Wong, N. D. (2019). Epidemiology of diabetes mellitus and cardiovascular disease. Current cardiology reports, 21(4), 1-8.

Group, U. P. D. S. (1998). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Bmj, 317(7160), 703-713.

Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., . . . Sowers, J. R. (1999). Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation, 100(10), 1134-1146.

Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019). Obesity, kidney dysfunction and hypertension: mechanistic links. Nature Reviews Nephrology, 15(6), 367-385.

Han, C., Rice, M. W., & Cai, D. (2016). Neuroinflammatory and autonomic mechanisms in diabetes and hypertension. American Journal of Physiology-Endocrinology and Metabolism, 311(1), E32-E41.

Herman, H., Ardani, I. G. A. I., Aryani, L. N. A., Windiani, I. G. A. T., Adnyana, I. G. N. S., & Setiawati, Y. (2022). Signs and symptoms of depression in children and adolescents with type 1 diabetes mellitus: A case report. International Journal of Health & Medical Sciences, 5(1), 150-153. https://doi.org/10.21744/ijhms.v5n1.1861

Hunter, R. W., Dhaun, N., & Bailey, M. A. (2022). The impact of excessive salt intake on human health. Nature Reviews Nephrology, 1-15.

Iloh, G. U. P., Chuku, A., Obiegbu, N. P., Ofoedu, J. N., & Ikwudinma, A. O. (2013). Frequency of cardiovascular risk factors in adult Nigerians with family history of non-communicable cardiovascular disease in a primary care clinic of a tertiary hospital in a resource-constrained environment of Eastern Nigeria. American Journal of Health Research, 1(1), 17-25.

Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005). Global burden of hypertension: analysis of worldwide data. The Lancet, 365(9455), 217-223.

Kemche, B., Saha Foudjo, B. U., & Fokou, E. (2020). Risk factors of hypertension among diabetic patients from Yaounde central hospital and Etoug-Ebe Baptist health centre, Cameroon. Journal of Diabetes Research, 2020.

Kondo, T., Nakano, Y., Adachi, S., & Murohara, T. (2019). Effects of tobacco smoking on cardiovascular disease. Circulation Journal, 83(10), 1980-1985.

Kostov, K., & Halacheva, L. (2018). Role of magnesium deficiency in promoting atherosclerosis, endothelial dysfunction, and arterial stiffening as risk factors for hypertension. International journal of molecular sciences, 19(6), 1724.

Kumara, W. N., Perera, T., Dissanayake, M., Ranasinghe, P., & Constantine, G. R. (2013). Prevalence and risk factors for resistant hypertension among hypertensive patients from a developing country. BMC research notes, 6(1), 1-7.

Lang, T., Barling, D., & Caraher, M. (2009). Food policy: integrating health, environment and society: OUP Oxford.

Lee, C. J., Hwang, J., Lee, Y.-h., Oh, J., Lee, S.-H., Kang, S.-M., . . . Park, S. (2018). Blood pressure level associated with lowest cardiovascular event in hypertensive diabetic patients. Journal of hypertension, 36(12), 2434-2443.

Lieb, W., Enserro, D. M., Sullivan, L. M., & Vasan, R. S. (2015). Residual cardiovascular risk in individuals on blood pressure–lowering treatment. Journal of the American Heart Association, 4(11), e002155.

Liu, G., Hu, Y., Zong, G., Pan, A., Manson, J. E., Rexrode, K. M., . . . Sun, Q. (2020). Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study. The Lancet Diabetes & Endocrinology, 8(2), 125-133.

Mekuria, A. B., Kifle, Z. D., & Melak, A. D. (2022). Level of knowledge, prevention practice, and predictors towards stroke among diabetic and hypertensive patients having a follow up at University of Gondar Comprehensive Specialized Referral Hospital, Northwest Ethiopia. A cross-sectional study. Clinical Epidemiology and Global Health, 100950.

Motala, A. A., Mbanya, J. C., Ramaiya, K., Pirie, F. J., & Ekoru, K. (2022). Type 2 diabetes mellitus in sub-Saharan Africa: challenges and opportunities. Nature Reviews Endocrinology, 1-11.

Nouh, F., Omar, M., & Younis, M. (2017). Prevalence of hypertension among diabetic patients in Benghazi: a study of associated factors. Asian Journal of Medicine and Health, 6(4), 1-11.

Osadnik, T., Pawlas, N., Lonnie, M., Osadnik, K., Lejawa, M., Wądołowska, L., . . . Gawlita, M. (2018). Family history of premature coronary artery disease (P-CAD)—A non-modifiable risk factor? Dietary patterns of young healthy offspring of P-CAD patients: A case-control study (MAGNETIC project). Nutrients, 10(10), 1488.

Pavlou, D. I., Paschou, S. A., Anagnostis, P., Spartalis, M., Spartalis, E., Vryonidou, A., . . . Siasos, G. (2018). Hypertension in patients with type 2 diabetes mellitus: Targets and management. Maturitas, 112, 71-77.

Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018). Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Canadian Journal of Cardiology, 34(5), 575-584.

Poykko, S. M., Kellokoski, E., Horkko, S., Kauma, H., Kesaniemi, Y. A., & Ukkola, O. (2003). Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes, 52(10), 2546-2553.

Ranasinghe, P., Cooray, D. N., Jayawardena, R., & Katulanda, P. (2015). The influence of family history of hypertension on disease prevalence and associated metabolic risk factors among Sri Lankan adults. BMC Public Health, 15(1), 1-9.

Sachdev, B. (2011). Prevalence of hypertension and associated risk factors among Nomad Tribe groups. JOURNAL OF ANTHROPOLOGY, 7, 125.

Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., . . . Ogurtsova, K. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice, 157, 107843.

Shao, C., Wang, J., Tian, J., & Tang, Y.-d. (2020). Coronary artery disease: from mechanism to clinical practice. Coronary Artery Disease: Therapeutics and Drug Discovery, 1-36.

Śliwińska-Mossoń, M., & Milnerowicz, H. (2017). The impact of smoking on the development of diabetes and its complications. Diabetes and Vascular Disease Research, 14(4), 265-276.

Sowers, J. R., Epstein, M., & Frohlich, E. D. (2001). Diabetes, hypertension, and cardiovascular disease: an update. Hypertension, 37(4), 1053-1059.

Sunkara, N., & Ahsan, C. H. (2017). Hypertension in diabetes and the risk of cardiovascular disease. Cardiovascular endocrinology, 6(1), 33.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864

Tadesse, K., Amare, H., Hailemariam, T., & Gebremariam, T. (2018). Prevalence of hypertension among patients with type 2 diabetes mellitus and its socio demographic factors in Nigist Ellen Mohamed Memorial Hospital Hosanna, Southern Ethiopia. J Diabetes Metab, 9(4), 4-10.

Tam, B. T., Morais, J. A., & Santosa, S. (2020). Obesity and ageing: Two sides of the same coin. Obesity Reviews, 21(4), e12991.

Tapela, N. M., Clifton, L., Tshisimogo, G., Gaborone, M., Madidimalo, T., Letsatsi, V., . . . Lockman, S. (2020). Prevalence and determinants of hypertension awareness, treatment, and control in Botswana: a nationally representative population-based survey. International journal of hypertension, 2020.

Tharaheswari, M., & Yogamoorthi, A. (2030). Studies on Dyslipidemia in Diabetic and Non Diabetic Hypertensive Patients. Studies, 3.

van den Berg, E., Kloppenborg, R. P., Kessels, R. P., Kappelle, L. J., & Biessels, G. J. (2009). Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1792(5), 470-481.

Venugopal, K., & Mohammed, M. (2014). Prevalence of hypertension in type-2 diabetes mellitus. CHRISMED Journal of Health and Research, 1(4), 223.

Vuori, I. (2018). World health organization and physical activity. Progress in Preventive Medicine, 3(1), e0012.

Weatherall, J., Paprocki, Y., Meyer, T. M., Kudel, I., & Witt, E. A. (2018). Sleep tracking and exercise in patients with type 2 diabetes mellitus (step-D): pilot study to determine correlations between Fitbit data and patient-reported outcomes. JMIR mHealth and uHealth, 6(6), e8122.